Join Now

Utah Life Sciences News & Events

Transit Scientific’s Cutting-Edge Scoring Sheath Platform Earns CE Mark Approval

May 20, 2021

Transit Scientific has announced that its XO Score® Scoring Sheath Platform has received CE Mark clearance in the European Union for treatment of peripheral artery disease and end stage renal disease. Last year, the company announced FDA clearance for the device.

We’ve been thrilled to see the effective low-pressure dilatation and luminal gain achieved using our XO Score platform to treat a broad range of lesion types,” said Greg Method, President of Transit Scientific in Park City, Utah.

“This CE Mark clearance is an important step forward in making this innovative technology available in Europe to improve patient care,” said Kelvyn Cullimore, president and CEO of BIoUtah.